Eurofins Pharmaceutical Product Testing BE… SA
20.0 FTEEurofins Pharmaceutical Product Testing BE… reported total assets of €3.21m at the end of the 2025 financial year (annual accounts filed with the NBB on 17 Jul 2026), with 20 full-time equivalents.
By total assets for 2025, Eurofins Pharmaceutical Product Testing BE… ranks among the 100 largest of the 843 companies in its sector (NACE 7120) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Eurofins Pharmaceutical Product Testing BE… shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity 0 % Total assets -36 % Headcount (avg FTE) +1 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Eurofins Pharmaceutical Product Testing BE…'s annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 103,882 € | ||||
| Equity | 816,310 € | ||||
| Cash | 677,242 € | ||||
| EBITDA | 316,288 € | ||||
| Total assets | €3.21m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 17 Jul 2026
- Year ended 31 Dec 2024filed on 30 Jun 2025
- Year ended 31 Dec 2023filed on 10 Jul 2024
- Year ended 31 Dec 2022filed on 10 Jul 2023
- Year ended 31 Dec 2021filed on 01 Jul 2022
Eurofins Pharmaceutical Product Testing BE…'s financial analysis
- Solvency25.4%sector median: 53.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Eurofins Pharmaceutical Product Testing BE…
1 active director(s) in the register.
Eurofins Pharmaceutical Product Testing BE…'s shareholders and holdings →Eurofins Pharmaceutical Product Testing BE…'s publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0435.237.515
- VAT number
- BE0435237515
- Peppol
- Registered · 0208:0435237515 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 09 Sep 1988
- Registered office
- 8200 Bruges
- Size
- Small · 20.0 FTE
- Latest accounts
- 2025 · filed on 17 Jul 2026
- Activity
- Other technical testing and analysis activities (NACE 71209)
Eurofins Pharmaceutical Product Testing BE… (SA) has been based in Bruges since 1988, active in: other technical testing and analysis activities. For 2025, it reports a net profit of 103,882 € and equity of 816,310 €; its revenue is not published. With 20.0 full-time equivalents, it is a small enterprise by headcount.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Eurofins Pharmaceutical Product Testing BE…
Companies in the same business, of comparable size and area, outside its group.
- Palmir Research and experimental development on natural sciences and engineering Wommelgem · balance sheet 4 €
- Biolynx Research and experimental development on natural sciences and engineering Ghent · balance sheet €1.49m
- Foodchain ID Testing solutions Technical testing and analysis Herstal · balance sheet €3.35m
- Lareco Technical testing and analysis Marche-en-Famenne · balance sheet €2.62m
- Forwise Technical testing and analysis Fleurus · balance sheet €2.13m
- European Control Services Technical testing and analysis Saint-Josse-ten-Noode · balance sheet €4.90m
- reMYND Technical testing and analysis Leuven · balance sheet €3.15m
- V.D.C. Engineering Technical testing and analysis Wavre · balance sheet 935,071 €
Frequently asked questions about Eurofins Pharmaceutical Product Testing BE…
What is the revenue of Eurofins Pharmaceutical Product Testing BE…?
Eurofins Pharmaceutical Product Testing BE… files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Eurofins Pharmaceutical Product Testing BE…?
In Belgium, the VAT number is the company number prefixed with BE: BE0435237515 for Eurofins Pharmaceutical Product Testing BE…, if the company is VAT-registered. Its company number (CBE) is 0435.237.515.
Where is the registered office of Eurofins Pharmaceutical Product Testing BE…?
According to the CBE register, the registered office of Eurofins Pharmaceutical Product Testing BE… is in 8200 Bruges.
What is the equity of Eurofins Pharmaceutical Product Testing BE…?
At the close of the 2025 financial year, the equity of Eurofins Pharmaceutical Product Testing BE… amounts to 816,310 €, a solvency of 25.4% of total assets.
How many people work at Eurofins Pharmaceutical Product Testing BE…?
20.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Eurofins Pharmaceutical Product Testing BE…?
The register lists 1 active mandates at Eurofins Pharmaceutical Product Testing BE…. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Eurofins Pharmaceutical Product Testing BE… within its sector?
By total assets for 2025, Eurofins Pharmaceutical Product Testing BE… ranks among the 100 largest of the 843 companies in its sector (NACE 7120) in Belgium that filed accounts for that financial year.
The full file of Eurofins Pharmaceutical Product Testing BE…
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →